Cellectis (FRA:ZVAA) Cyclically Adjusted Book per Share: €5.02 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:ZVAA Cellectis SA FRA:ZVAA
64 GF Score
Price €2.40
GF Value €3.06
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Cellectis Cyclically Adjusted Book per Share?

Cellectis FRA:ZVAA 64 Cyclically Adjusted Book per Share is €5.02 as of Mar. 2026. GuruFocus rates FRA:ZVAA with a GF Score™ of 64/100 and a GF Value™ of €3.06 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Cellectis's adjusted book value per share for the three months ended in Mar. 2026 was €0.515. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €5.02 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Cellectis's average Cyclically Adjusted Book Growth Rate was -11.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -4.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Cellectis was 0.30% per year. The lowest was -4.20% per year. And the median was -1.95% per year.

As of today (2026-07-17), Cellectis's current stock price is €2.40. Cellectis's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €5.02. Cellectis's Cyclically Adjusted PB Ratio of today is 0.48.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Cellectis was 1.76. The lowest was 0.15. And the median was 0.41.


Cellectis  (FRA:ZVAA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Cellectis's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=2.40/5.02
=0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Cellectis was 1.76. The lowest was 0.15. And the median was 0.41.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Cellectis Cyclically Adjusted Book per Share Related Terms


Cellectis Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Cellectis's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cellectis Cyclically Adjusted Book per Share Chart

Cellectis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.60 6.56 6.48 5.04 5.34

Cellectis Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.58 5.32 5.48 5.34 5.02

FRA:ZVAA vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Cellectis's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cellectis Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cellectis's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cellectis's Cyclically Adjusted PB Ratio falls into.


FRA:ZVAA
64GF Score
Cellectis SA FRA:ZVAA
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cellectis Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cellectis's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.515/122.4200*122.4200
=0.515

Current CPI (Mar. 2026) = 122.4200.

Cellectis Quarterly Data

Book Value per Share CPI Adj_Book
201606 7.141 100.630 8.687
201609 7.174 100.340 8.753
201612 7.319 100.650 8.902
201703 7.124 101.170 8.620
201706 6.648 101.320 8.032
201709 6.595 101.330 7.968
201712 6.224 101.850 7.481
201803 5.741 102.750 6.840
201806 9.038 103.370 10.704
201809 8.698 103.560 10.282
201812 8.479 103.470 10.032
201903 8.159 103.890 9.614
201906 7.586 104.580 8.880
201909 7.287 104.500 8.537
201912 6.679 104.980 7.789
202003 7.072 104.590 8.278
202006 6.429 104.790 7.511
202009 5.802 104.550 6.794
202012 5.453 104.960 6.360
202103 5.112 105.750 5.918
202106 5.037 106.340 5.799
202109 4.448 106.810 5.098
202112 4.306 107.850 4.888
202203 3.813 110.490 4.225
202206 3.511 112.550 3.819
202209 3.029 112.740 3.289
202212 2.438 114.160 2.614
202303 1.911 116.790 2.003
202306 1.603 117.650 1.668
202309 1.283 118.260 1.328
202312 1.082 118.390 1.119
202403 1.158 119.470 1.187
202406 1.379 120.200 1.404
202409 1.165 119.560 1.193
202412 1.250 119.950 1.276
202503 1.072 120.380 1.090
202506 0.839 121.360 0.846
202509 0.853 120.950 0.863
202512 0.646 120.900 0.654
202603 0.515 122.420 0.515

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €5.02 mean?
Cellectis (FRA:ZVAA) has a Cyclically Adjusted Book per Share of €5.02 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Cellectis and its competitors.
Is Cellectis' Cyclically Adjusted Book per Share too high?
Cellectis' current Cyclically Adjusted Book per Share is €5.02. Overall, Cellectis has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cellectis' Cyclically Adjusted Book per Share compare to VRTX and REGN?
Cellectis' Cyclically Adjusted Book per Share of €5.02 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Cellectis and its competitors. Cellectis's current Cyclically Adjusted Book per Share is €5.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cellectis stock overvalued right now?
Based on GuruFocus' analysis, Cellectis (FRA:ZVAA) is currently considered Modestly Undervalued. The stock's GF Value™ is €3.06, compared to a current price of €2.40 — trading 21.6% below its estimated fair value. The current Cyclically Adjusted Book per Share is €5.02. Cellectis' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Cellectis (FRA:ZVAA), the current Cyclically Adjusted Book per Share is €5.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cellectis (FRA:ZVAA) Overvalued in 2026?

Based on GuruFocus' analysis, Cellectis stock appears to be undervalued. The current stock price of €2.40 is trading 21.6% below its estimated GF Value™ of €3.06. GuruFocus considers Cellectis to be Modestly Undervalued.

Key valuation signals for FRA:ZVAA:

  • Cyclically Adjusted Book per Share: €5.02
  • GF Value™: €3.06 vs. price of €2.40 (21.6% below fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the FRA:ZVAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cellectis Business Description

Address 8, rue de la Croix Jarry, Paris, FRA, 75013
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
64GF Score

Get the complete analysis for FRA:ZVAA

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.40
Price
€3.06
GF Value